These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid concentrations in cerebral cortex following systemic endotoxin administration. Heyes MP; Quearry BJ Adv Exp Med Biol; 1991; 294():559-62. PubMed ID: 1722952 [No Abstract] [Full Text] [Related]
4. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Saito K; Markey SP; Heyes MP Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184 [TBL] [Abstract][Full Text] [Related]
5. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy. Moroni F; Lombardi G; Carlà V; Pellegrini D; Carassale GL; Cortesini C J Neurochem; 1986 Mar; 46(3):869-74. PubMed ID: 2419500 [TBL] [Abstract][Full Text] [Related]
7. Decrease in rat cerebral quinolinic acid concentration following chronic hydrocortisone treatment. Connick J; Lombardi G; Beni M; Moroni F Neurosci Lett; 1988 May; 88(2):216-20. PubMed ID: 2454438 [TBL] [Abstract][Full Text] [Related]
8. Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading. During MJ; Heyes MP; Freese A; Markey SP; Martin JB; Roth RH Brain Res; 1989 Jan; 476(2):384-7. PubMed ID: 2522807 [TBL] [Abstract][Full Text] [Related]
9. Brain and plasma quinolinic acid in profound insulin-induced hypoglycemia. Heyes MP; Papagapiou M; Leonard C; Markey SP; Auer RN J Neurochem; 1990 Mar; 54(3):1027-33. PubMed ID: 1689373 [TBL] [Abstract][Full Text] [Related]
10. Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading. During MJ; Freese A; Heyes MP; Swartz KJ; Markey SP; Roth RH; Martin JB FEBS Lett; 1989 Apr; 247(2):438-44. PubMed ID: 2523822 [TBL] [Abstract][Full Text] [Related]
11. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression. Laugeray A; Launay JM; Callebert J; Surget A; Belzung C; Barone PR Behav Brain Res; 2010 Jun; 210(1):84-91. PubMed ID: 20153778 [TBL] [Abstract][Full Text] [Related]
12. [Kynurenines in pathogenesis of endogenous psychiatric disorders]. Shilov IuE; Bezrukov MV Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637 [TBL] [Abstract][Full Text] [Related]
13. Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Saito K; Markey SP; Heyes MP Brain Res; 1991 Apr; 546(1):151-4. PubMed ID: 1830237 [TBL] [Abstract][Full Text] [Related]
14. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. Kita T; Morrison PF; Heyes MP; Markey SP J Neurochem; 2002 Jul; 82(2):258-68. PubMed ID: 12124427 [TBL] [Abstract][Full Text] [Related]
15. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831 [TBL] [Abstract][Full Text] [Related]
16. Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study. Kruse JL; Cho JH; Olmstead R; Hwang L; Faull K; Eisenberger NI; Irwin MR Psychoneuroendocrinology; 2019 Nov; 109():104371. PubMed ID: 31325802 [TBL] [Abstract][Full Text] [Related]
17. Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats. Speciale C; Ungerstedt U; Schwarcz R Neurosci Lett; 1989 Oct; 104(3):345-50. PubMed ID: 2530475 [TBL] [Abstract][Full Text] [Related]
18. Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. Moroni F; Russi P; Gallo-Mezo MA; Moneti G; Pellicciari R J Neurochem; 1991 Nov; 57(5):1630-5. PubMed ID: 1833509 [TBL] [Abstract][Full Text] [Related]
19. Monitoring of kynurenine pathway metabolites, neurotransmitters and their metabolites in blood plasma and brain tissue of individuals with latent toxoplasmosis. Vondroušová J; Mikoška M; Syslová K; Böhmová A; Tejkalová H; Vacek L; Kodym P; Krsek D; Horáček J J Pharm Biomed Anal; 2019 Jun; 170():139-152. PubMed ID: 30925271 [TBL] [Abstract][Full Text] [Related]
20. Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior. Eskelund A; Li Y; Budac DP; Müller HK; Gulinello M; Sanchez C; Wegener G J Neurochem; 2017 Jul; 142(1):118-131. PubMed ID: 28407315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]